Midway Immunology and Research Center
Welcome,         Profile    Billing    Logout  
 1 Trial 
10 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lalezari, Jay
NCT05275998: TMB-365 and TMB-380 in Suppressed HIV-1 Infected Individuals

Recruiting
1/2
90
US
TMB-365/TMB-380, TMB-380 is also known as VRC07-523-LS
TaiMed Biologics Inc.
HIV-1-infection
04/24
07/24
Rappo, Urania
NCT05240300: A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis

Not yet recruiting
1b/2a
48
NA
BX005-A, Placebo
BiomX, Inc., Maruho Co., Ltd.
Atopic Dermatitis
06/23
06/23
NCT05010577: Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection

Active, not recruiting
1b/2a
32
Europe, US, RoW
BX004-A, Bacteriophage, Placebo, Vehicle buffer
BiomX, Inc.
Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis
10/23
03/24
Jacobs, Brenda
NCT05275998: TMB-365 and TMB-380 in Suppressed HIV-1 Infected Individuals

Recruiting
1/2
90
US
TMB-365/TMB-380, TMB-380 is also known as VRC07-523-LS
TaiMed Biologics Inc.
HIV-1-infection
04/24
07/24
Ramgopal, Moti N
VOLITION, NCT05917509: A Study to Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy

Active, not recruiting
3
171
Europe, Canada, US, RoW
DTG/3TC, Dovato, Cabotegravir (CAB) LA, Vocabria, Rilpivirine (RPV) LA, Rekambys
ViiV Healthcare, GlaxoSmithKline, PPD
HIV Infections
08/25
08/26
B-Well 2, NCT05630820 / 2022-002268-53: Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B

Active, not recruiting
3
859
Europe, Canada, Japan, US, RoW
Bepirovirsen, Placebo
GlaxoSmithKline, GlaxoSmithKline Research & Development Limited
Chronic Hepatitis B, Hepatitis B, Chronic
11/25
05/26
NCT05869643: A Clinical Trial of STP0404 in Adults With HIV-1 Infection

Recruiting
2
36
US
Low-dose STP0404 (Pirmitegravir), Medium-dose STP0404 (Pirmitegravir), High-dose STP0404 (Pirmitegravir), Placebo
ST Pharm Co., Ltd.
HIV-1-infection
10/24
11/24
NCT06061081: A Study to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of VH3739937 in in Treatment-Naive Adults Living With HIV-1

Not yet recruiting
2
26
Europe, US, RoW
VH3739937, Placebo
ViiV Healthcare
HIV Infections
06/24
06/24
EMBRACE, NCT05996471: A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)

Active, not recruiting
2
99
US
VH3810109, Cabotegravir, Standard of care (SOC), rHuPH20
ViiV Healthcare
HIV Infections
11/24
05/26
NCT05275998: TMB-365 and TMB-380 in Suppressed HIV-1 Infected Individuals

Recruiting
1/2
90
US
TMB-365/TMB-380, TMB-380 is also known as VRC07-523-LS
TaiMed Biologics Inc.
HIV-1-infection
04/24
07/24

Download Options